# Spanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy.

> **NCT04285866** · — · COMPLETED · sponsor: **Fundación GECP** · enrollment: 245 (actual)

## Conditions studied

- Small Cell Lung Cancer (SCLC)

## Interventions

- **DRUG:** Durvalumab

## Key facts

- **NCT ID:** NCT04285866
- **Lead sponsor:** Fundación GECP
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-21
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2022-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04285866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04285866, "Spanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04285866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*